Following the annual National Lung Cancer Audit (NCLA) report, the pandemic exacerbated the challenges clinicians face in proving adequate lung cancer care. Neal Navani, MA, MRCP, MSc, PhD, Care Quality Improvement Department, Royal College of Physicians, London, UK, comments on what needs to be done to optimize lung cancer outcomes in patients. Reestablishment of initiatives such as low dosage CT screening programs have shown to reduce mortality, and awareness campaigns can increase diagnosis rates among symptomatic patients. However, further work is needed to reduce emergency presentations of lung cancer. This interview took place at the 20th Annual British Thoracic Oncology Group (BTOG) Conference 2022.